首页> 美国政府科技报告 >NMDA Antagonist, MK-801, Suppresses Long-Term Potentiation, Kindling, and Kindling-Induced Potentiation in the Perforant Path of the Unanesthetized Rat
【24h】

NMDA Antagonist, MK-801, Suppresses Long-Term Potentiation, Kindling, and Kindling-Induced Potentiation in the Perforant Path of the Unanesthetized Rat

机译:NmDa拮抗剂,mK-801,抑制未麻醉大鼠穿孔路径中的长期增强,点燃和点燃诱导的增强作用

获取原文

摘要

Antagonism of NMDA-mediated transmission by MK-801 has been shown to block long-term potentiation (LTP) in vitro and delay electrical kindling of the amygdala. The experiment sought to examine the relationship between synaptic potentiation of the perforant path-granule cell synapse and development of perforant path kindling. MK-801 (0.1 and 1.0 mg/kg) blocked induction of LTP of the perforant path in the unanesthetized animal measured 24 h after train delivery. The 1.0 mg/kg dosage also increased afterdischarge (AD) thresholds, delayed kindling development from daily stimulation of the perforant path (x = 8.82 + or - and 22.9 + or - 3.66 sessions to the first stage 5 seizure), and increased AD durations. Kindling produced a significant potentiation of the EPSP (47%) and population spike (49%) after the first evoked AD in control animals. No significant enhancement of either component of the field potential was observed in MD-801-treated animals. Animals treated with this dosage of MD-801, did, however, kindle in the absence of potentiation at this synapse. It was concluded that although NMDA-mediated potentiation may facilitate kindling, synaptic potentiation does not appear to be a critical requirement for kindling to develop. (Copyright (c) 1990 Elsevier Science Publishers B.V.)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号